SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?

Authors :: Mone P
Ciccarelli M
Jankauskas SS
Guerra G
Vecchione C
Visco V
Santulli G
Source :: The lancet. Healthy longevity [Lancet Healthy Longev] 2024 Sep; Vol. 5 (9), pp. 100632. Date of Electronic Publication: 2024 Sep 13.
Publication Year :: 2024
Abstract: Competing Interests: We declare no conflicting interests.

Subjects :: Humans
Aged
Hypoglycemic Agents therapeutic use
Hypoglycemic Agents pharmacology
Diabetes Mellitus, Type 2 drug therapy
Glucagon-Like Peptide-1 Receptor Agonists
Sodium-Glucose Transporter 2 Inhibitors therapeutic use
Glucagon-Like Peptide-1 Receptor agonists
Frailty drug therapy

Full Text Access

Tools